Literature DB >> 19246419

Adherence with adjuvant hormonal therapy for breast cancer.

K J Ruddy, A H Partridge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19246419     DOI： 10.1093/annonc/mdp039

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  17 in total

1.  Breast cancer: Tamoxifen--when more might be better.

Authors:  Carlos Caldas; Ian F Tannock
Journal:  Nat Rev Clin Oncol       Date:  2013-02-05       Impact factor: 66.675

2.  Adherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-up.

Authors:  Renée Simon; Jean Latreille; Claire Matte; Pierre Desjardins; Eric Bergeron
Journal:  Can J Surg       Date:  2014-02       Impact factor: 2.089

3.  Age-specific nonpersistence of endocrine therapy in postmenopausal patients diagnosed with hormone receptor-positive breast cancer: a TEAM study analysis.

Authors:  Willemien van de Water; Esther Bastiaannet; Elysée T M Hille; Elma M Meershoek-Klein Kranenbarg; Hein Putter; Caroline M Seynaeve; Robert Paridaens; Anton J M de Craen; Rudi G J Westendorp; Gerrit-Jan Liefers; Cornelis J H van de Velde
Journal:  Oncologist       Date:  2011-12-30

Review 4.  Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.

Authors:  Balazs I Bodai; Phillip Tuso
Journal:  Perm J       Date:  2015

5.  Self-Care Support for Patients with Gastrointestinal Cancer: iCancerHealth.

Authors:  Donna L Berry; Traci M Blonquist; Manan M Nayak; Nina Grenon; Thaer G Momani; Nadine J McCleary
Journal:  Appl Clin Inform       Date:  2018-11-21       Impact factor: 2.342

6.  Inconsistent labeling of food effect for oral agents across therapeutic areas: differences between oncology and non-oncology products.

Authors:  Soonmo Peter Kang; Mark J Ratain
Journal:  Clin Cancer Res       Date:  2010-08-24       Impact factor: 12.531

7.  Predictors of adherence to pharmacological and behavioral treatment in a cessation trial among smokers in Aleppo, Syria.

Authors:  Ziyad Ben Taleb; Kenneth D Ward; Taghrid Asfar; Raed Bahelah; Wasim Maziak
Journal:  Drug Alcohol Depend       Date:  2015-06-06       Impact factor: 4.492

8.  Influence of compliance on bone mineral density changes in postmenopausal women with early breast cancer on Anastrozole.

Authors:  Matthias Kalder; Volker Ziller; Ioannis Kyvernitakis; Dana Knöll; Olaf Hars; Peyman Hadji
Journal:  J Cancer Res Clin Oncol       Date:  2013-02-27       Impact factor: 4.553

9.  Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer.

Authors:  Erin J Aiello Bowles; Denise M Boudreau; Jessica Chubak; Onchee Yu; Monica Fujii; Janet Chestnut; Diana S M Buist
Journal:  J Oncol Pract       Date:  2012-07-17       Impact factor: 3.840

10.  Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence.

Authors:  Jacquie H Chirgwin; Anita Giobbie-Hurder; Alan S Coates; Karen N Price; Bent Ejlertsen; Marc Debled; Richard D Gelber; Aron Goldhirsch; Ian Smith; Manuela Rabaglio; John F Forbes; Patrick Neven; István Láng; Marco Colleoni; Beat Thürlimann
Journal:  J Clin Oncol       Date:  2016-05-23       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.